C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 Trial)

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 635-638

  Moghbeli, Nazanin ^a   Kirtane, Ajay J ^b   Ray, Kausik K ^a   Murphy, Sabina A ^a   Gibson, C Michael ^b   Braunwald, Eugene ^a   Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY RISK; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SMOKING; ST SEGMENT ELEVATION;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; HUMANS; LUNG DISEASES; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL RATE; SYNDROME;

EID: 23944470602     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.033     Document Type: Article

References (20)

1. L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, P.K. Whelton Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States Ann Intern Med 138 2003 891 897
2. E.A. Bermudez, N. Rifai, J.E. Buring, J.E. Manson, P.M. Ridker Relation between markers of systemic vascular inflammation and smoking in women Am J Cardiol 89 2002 1117 1119
3. S.A. Harding, J. Sarma, D.H. Josephs, N.L. Cruden, J.N. Din, P.J. Twomey, K.A. Fox, D.E. Newby Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers Circulation 109 2004 1926 1929
4. P. Lind, G. Engstrom, L. Stavenow, L. Janzon, F. Lindgarde, B. Hedblad Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins Arterioscler Thromb Vasc Biol 24 2004 577 582
5. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, N. Lakkis, F.J. Neumann, D.H. Robertson, P.T. DeLucca, P.M. DiBattiste Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
6. D.A. Morrow, N. Rifai, E.M. Antman, D.L. Weiner, C.H. McCabe, C.P. Cannon, E. Braunwald C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis In Myocardial Infarction J Am Coll Cardiol 31 1998 1460 1465
7. D.A. Morrow, C.P. Cannon, N. Rifai, M.J. Frey, R. Vicari, N. Lakkis, D.H. Robertson, D.A. Hille, P.T. DeLucca, P.M. DiBattiste Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction results from a randomized trial JAMA 286 2001 2405 2412
8. C.M. Gibson, C.P. Cannon, W.L. Daley, J.T. Dodge Jr, B. Alexander Jr, S.J. Marble, C.H. McCabe, L. Raymond, T. Fortin, W.K. Poole, E. Braunwald TIMI frame count a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
9. C.M. Gibson, C.P. Cannon, S.A. Murphy, K.A. Ryan, R. Mesley, S.J. Marble, C.H. McCabe, F. Van De Werf, E. Braunwald Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
10. R. Doll, R. Peto, K. Wheatley, R. Gray, I. Sutherland Mortality in relation to smoking 40 years' observations on male Br doctors BMJ 309 1994 901 911
11. G. Howard, L.E. Wagenknecht, G.L. Burke, A. Diez-Roux, G.W. Evans, P. McGovern, F.J. Nieto, G.S. Tell Cigarette smoking and progression of atherosclerosis the Atherosclerosis Risk in Communities (ARIC) Study JAMA 279 1998 119 124
12. P.M. Ridker, J.E. Buring, N.R. Cook, N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events an 8-year follow-up of 14719 initially healthy American women Circulation 107 2003 391 397
13. A. Sambola, J. Osende, J. Hathcock, M. Degen, Y. Nemerson, V. Fuster, J. Crandall, J.J. Badimon Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity Circulation 107 2003 973 977
14. P.L. Giesen, U. Rauch, B. Bohrmann, D. Kling, M. Roque, J.T. Fallon, J.J. Badimon, J. Himber, M.A. Riederer, Y. Nemerson Blood-borne tissue factor another view of thrombosis Proc Natl Acad Sci USA 96 1999 2311 2315
15. V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S.D. Gertz, A. Fernandez-Ortiz, J.H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, J.J. Badimon Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
16. D. Ardissino, P.A. Merlini, K.A. Bauer, E. Bramucci, M. Ferrario, R. Coppola, R. Fetiveau, S. Lucreziotti, R.D. Rosenberg, P.M. Mannucci Thrombogenic potential of human coronary atherosclerotic plaques Blood 98 2001 2726 2729
17. P.L. Giesen, B.S. Fyfe, J.T. Fallon, M. Roque, M. Mendlowitz, M. Rossikhina, A. Guha, J.J. Badimon, Y. Nemerson, M.B. Taubman Intimal tissue factor activity is released from the arterial wall after injury Thromb Haemost 83 2000 622 628
18. J.J. Badimon, M. Lettino, V. Toschi, V. Fuster, M. Berrozpe, J.H. Chesebro, L. Badimon Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions Circulation 99 1999 1780 1787
19. B. Lindahl, E. Diderholm, B. Lagerqvist, P. Venge, L. Wallentin Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease a FRISC II substudy J Am Coll Cardiol 38 2001 979 986
20. C. Heeschen, M.J. van Den Brand, C.W. Hamm, M.L. Simoons Angiographic findings in patients with refractory unstable angina according to troponin T status Circulation 100 1999 1509 1514